Search
for
Sort by
Research 61–90 of 131
- The Rise of Medical Questionnaires in Telemedicine. Will they Initiate a Paradigm Shift in Medicine?
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- This Month in Adult Urology
- MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Direct Vasodilators and Sympatholytic Agents
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- Voltammetric sensing of minoxidil using a molecularly imprinted polymer (MIP)-modified carbon paste electrode
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- Sildenafil: Looking Beyond Erectile Dysfunction: A Dermatological Perspective
- Lower Urinary Tract Symptoms in Men
- Identification of Established Drugs for Contemporary Indications: A Hospital Based Study
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- A systematic review on Drug Re-profiling/Re-Purposing
- The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Lower Urinary Tract Symptoms in the Elderly Male: Choosing Wisely
- Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors
- Safety and Efficacy of the Coadministration of Sildenafil and Finasteride
- Steroid induced central serous retinopathy following follicular unit extraction in androgenic alopecia
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Back to the Roots—An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Lipid-Based Drug Delivery Systems in Regenerative Medicine
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia